223 related articles for article (PubMed ID: 18336890)
1. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
Wang C; Sun Y; Han R
Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.
Hu Z; Ma H; Chen F; Wei Q; Shen H
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1810-8. PubMed ID: 16030121
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
5. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis.
Zheng H; Wang Z; Shi X; Wang Z
Lung Cancer; 2009 Sep; 65(3):268-73. PubMed ID: 19329222
[TBL] [Abstract][Full Text] [Related]
7. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
[TBL] [Abstract][Full Text] [Related]
8. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
11. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
Stern MC; Siegmund KD; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
[TBL] [Abstract][Full Text] [Related]
13. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
Lao T; Gu W; Huang Q
Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population.
Zhang Z; Wan J; Jin X; Jin T; Shen H; Lu D; Xia Z
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2614-9. PubMed ID: 16284386
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
18. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk.
Yu HP; Zhang XY; Wang XL; Shi LY; Li YY; Li F; Su YH; Wang YJ; Lu B; Sun X; Lu WH; Xu SQ
Cancer Detect Prev; 2004; 28(3):194-9. PubMed ID: 15225899
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
